| 1 | Morales-Cano D, Calviño E, Rubio V, et al. Apoptosis induced by pacl*taxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition [J]. Exp Toxicol Pathol, 2013, 65(7-8):1101-1108. |
| 2 | Ranjeeta B, Rajender RK. Drug-induced liver injury due to cancer chemotherapeutic agents [J]. Semin Liver Dis, 2014, 34(2):162-171. |
| 3 | Capel ID, Jenner M, Dorrell HM, et al. Hepatic function assessed (in rats) during chemotherapy with some anti-cancer drugs [J]. Clin Chem, 1979, 25(8):1381-1383. |
| 4 | Khan H, Nabavi SM, Sureda A, et al. Therapeutic potential of songorine, a diterpenoid alkaloid of the genus Aconitum[J]. Eur J Med Chem, 2018, 153:29-33. |
| 5 | Stage TB, Bergmann TK, Kroetz DL. Clinical pharmaco*kinetics of pacl*taxel monotherapy: an updated literature review [J]. Clini Pharmaco*kinet, 2017, 57(1):7-19. |
| 6 | Jin Y, Hu W, Liu Tet al. Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to pacl*taxel [J]. Cancer Lett, 2018, 419:233-244. |
| 7 | Li W, Chen Z, Shen S, et al. Protective effect of magnesium isoglycyrrhizinate combinated with verapamil on liver ischemia-reperfusion injury after semi-hepatectomy in rats [J]. Zhonghua Yi Xue Za Zhi, 2015, 95(38):3119-3123. |
| 8 | Wang W, Li X, Xu J. Magnesium isoglycyrrhizinate attenuates D-galactosamine/lipopolysaccharides induced acute liver injury of rat via regulation of the p38-MAPK and NF-κB signaling pathways [J]. Immunopharmacol Immunotoxicol, 2018, 40(3):262-267. |
| 9 | Zou X, Wang Y, Peng C, et al. Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin-induced model of liver injury [J]. Int J Mol Med, 2018, 42(4):2020-2030. |
| 10 | Wang Y, Wang Z, Gao M, et al. Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug‐induced liver injury: A phase II trial [J]. Liver Int, 2019, 39(11):2102-2111. |
| 11 | Bocci G, Di Paolo A, Danesi R. The pharmacological bases of the antiangiogenic activity of pacl*taxel [J]. Angiogenesis, 2013, 16(3):481-492. |
| 12 | Maha HS, Noha A, Nirmeen M, et al. Pacl*taxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc [J]. Life Sci, 2018, 211:245-251. |
| 13 | Yang Q, Zhang D, Li Y, et al. Pacl*taxel alleviated liver injury of septic mice by alleviating inflammatory response via microRNA-27a/TAB3/NF-κB signaling pathway [J]. Biomed Pharmacother, 2018, 97:1424-1433. |
| 14 | Ali C, Ertan B, Belge KE, et al. N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats [J]. Med Sci Monit, 2006, 12(8):BR274-278. |
| 15 | Jing ZT, Liu W, Xue CR, et al. AKT activator SC79 protects hepatocytes from TNF-α-mediated apoptosis and alleviates d-Gal/LPS-induced liver injury [J]. Am J Physiol Gastrointest Liver Physiol, 2019, 316(3): G387-G396. |
| 16 | Malik G, Wilting J, Hess CF, et al. PECAM-1 modulates liver damage induced by synergistic effects of TNF-α and irradiation [J]. J Cell Mol Med, 2019, 23(5):3336-3344. |
| 17 | Afrin R, Arumugam S, Rahman A, et al. Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation [J]. Int Immunopharmacol, 2017, 44:174-182. |
| 18 | Huang L, Zhao Z, Duan C, et al. Lactobacillus plantarum C88 protects against aflatoxin B(1)-induced liver injury in mice via inhibition of NF-κB-mediated inflammatory responses and excessive apoptosis [J]. BMC Microbiol, 2019, 19(1):170. |
| 19 | Sun Y, Gu J, Liu R, et al. IL-2/IL-6 ratio correlates with liver function and recovery in acute liver injury patients [J]. APMIS, 2019, 127(6):468-474. |
| 20 | Yousefi A, Zare Bidoki A, Shafioyoun A, et al. Association of IL-10 and TGF-beta cytokine gene polymorphisms with autoimmune hepatitis [J]. Clin Res Hepatol Gastroenterol, 2019, 43(1):45-50. |
| [1] | 李文金, 薛庆云. 白细胞介素家族炎性细胞因子在骨关节炎中的研究进展[J]. 中华关节外科杂志(电子版), 2023, 17(03): 348-353. |
| [2] | 张巧梅, 孙小平, 李冠胜, 邓扬嘉. 针灸对大鼠呼吸机相关性肺炎中性粒细胞归巢及胞外诱捕网的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 265-271. |
| [3] | 陈腊青, 林佳佳, 毛洪刚, 童冠海, 汪梦娜, 夏红波, 刘卓, 徐海霞, 赵玉华, 张传领. 血清细胞因子及呼出气一氧化氮在哮喘-慢性阻塞性肺疾病重叠综合征中的临床意义[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 316-320. |
| [4] | 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549. |
| [5] | 靳茜雅, 黄晓松, 谭诚, 蒋琴, 侯昉, 李瑶悦, 徐冰, 贾红慧, 刘文英. 产前他克莫司治疗对先天性膈疝大鼠病理模型肺血管重构的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 428-436. |
| [6] | 魏强, 张明祥, 陈强谱, 孙宝房. 增味小承气汤对梗阻性黄疸大鼠胃肠道动力的影响[J]. 中华普通外科学文献(电子版), 2023, 17(04): 267-270. |
| [7] | 李永浩, 高雪菲, 郭田田, 张进, 张彩针, 刘静. 肥胖合并甲状腺癌相关机制的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 311-315. |
| [8] | 黄彩英, 陈萍, 潘杰, 莫彩云, 尚敏红, 周俊. 紫杉醇治疗胸腺鳞癌致大疱性表皮松解坏死性药疹救治成功一例[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 442-444. |
| [9] | 沃吟晴, 杨向群. 心脏巨噬细胞的生理功能及在心肌梗死后的作用[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 167-171. |
| [10] | 杨蕴钊, 周诚, 石美涵, 赵静, 白雪源. 人羊水间充质干细胞对膜性肾病大鼠的治疗作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 181-186. |
| [11] | 陈蕊, 杨洪娜, 方巍, 李鑫鑫, 李甜甜, 于孝义, 王艳雪, 李文玉. 血清与支气管肺泡灌洗液中细胞因子水平与肺内外ARDS的相关性研究[J]. 中华重症医学电子杂志, 2023, 09(03): 251-258. |
| [12] | 萨仁高娃, 张英霞, 邓伟, 闫诺, 樊宁. 超声引导下鼠肝消融术后组织病理特征的变化规律及影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 394-398. |
| [13] | 王小红, 钱晶, 翁文俊, 周国雄, 朱顺星, 祁小鸣, 刘春, 王萍, 沈伟, 程睿智, 秦璟灏. 巯基丙酮酸硫基转移酶调控核因子κB信号介导自噬对重症急性胰腺炎大鼠的影响及机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 422-426. |
| [14] | 刘立业, 赵德芳. 非酒精性脂肪肝患者血清细胞因子信号转导抑制因子3、肝X受体α水平与CT影像学特征的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 211-215. |
| [15] | 曹文玺, 陈箫, 竺来法, 周永平. 尼妥珠单抗联合白蛋白结合型紫杉醇治疗胰腺癌的有效性及安全性分析[J]. 中华临床医师杂志(电子版), 2023, 17(04): 409-413. |
